Extracranial Systemic Embolic Events in Patients With Nonvalvular Atrial Fibrillation: Incidence, Risk Factors, and Outcomes
- PMID: 26224811
- DOI: 10.1161/CIRCULATIONAHA.114.013243
Extracranial Systemic Embolic Events in Patients With Nonvalvular Atrial Fibrillation: Incidence, Risk Factors, and Outcomes
Abstract
Background: Nonvalvular atrial fibrillation is a major cause of thromboembolic events. In comparison with atrial fibrillation-related stroke, extracranial systemic embolic events (SEEs) remain poorly defined.
Methods and results: All suspected SEEs reported among 37 973 participants of 4 large contemporary randomized clinical trials of anticoagulation in atrial fibrillation were independently readjudicated for clinical and objective evidence of sudden loss of perfusion of a limb or organ. Over 91 746 patient-years of follow-up, 221 SEEs occurred in 219 subjects. The SEE incidence was 0.24 of 100 and stroke incidence was 1.92 of 100 patient-years. In comparison with patients with stroke, those with SEE were more often female (56% versus 47%; P=0.01) and had comparable mean age (73.1±8.5 versus 73.5±8.8 years; P=0.57) and mean CHADS2 scores (2.4±1.3 versus 2.5±1.2; P=0.33). SEEs more frequently involved the lower extremity (58%) than visceral-mesenteric (31%) or upper extremity (10%). SEE-related care involved clinic assessment alone in 5%, 30% were hospitalized without procedures, 60% underwent endovascular or surgical intervention, and 5% underwent amputation. Within 30 days, 54% of patients recovered fully, 20% survived with deficits, and 25% died. Thirty-day mortality was greater after visceral-mesenteric than lower- or upper-extremity SEE (55%, 17%, and 9%, respectively, P≤0.0001). The relative risk of death throughout follow-up was 4.33 (95% confidence interval, 3.29-5.70) after SEE versus 6.79 (95% confidence interval, 6.22-7.41) after stroke in comparison with patients without either event.
Conclusions: SEE constituted 11.5% of clinically recognized thromboembolic events in patients with atrial fibrillation and was associated with high morbidity and mortality. SEE mortality was comparable to that of ischemic stroke and varied by anatomic site.
Keywords: arrhythmias, cardiac; atrial fibrillation; embolism; peripheral artery disease; risk factors.
© 2015 American Heart Association, Inc.
Comment in
-
Systemic Embolic Events (SEE) in Atrial Fibrillation: SEEing Embolic Risk More Clearly.Circulation. 2015 Sep 1;132(9):787-9. doi: 10.1161/CIRCULATIONAHA.115.018172. Epub 2015 Jul 29. Circulation. 2015. PMID: 26224812 Free PMC article. No abstract available.
-
Atrial fibrillation. Risk of systemic emboli in AF.Nat Rev Cardiol. 2015 Oct;12(10):561. doi: 10.1038/nrcardio.2015.126. Epub 2015 Aug 18. Nat Rev Cardiol. 2015. PMID: 26283268 No abstract available.
Similar articles
-
Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts.Circulation. 2013 Jan 15;127(2):224-32. doi: 10.1161/CIRCULATIONAHA.112.107128. Epub 2012 Dec 3. Circulation. 2013. PMID: 23212720 Clinical Trial.
-
Incidence of Stroke or Systemic Embolism in Paroxysmal Versus Sustained Atrial Fibrillation: The Fushimi Atrial Fibrillation Registry.Stroke. 2015 Dec;46(12):3354-61. doi: 10.1161/STROKEAHA.115.010947. Epub 2015 Oct 29. Stroke. 2015. PMID: 26514188 Clinical Trial.
-
Incidence of ischemic stroke and systemic embolism in patients with hypertrophic cardiomyopathy, nonvalvular atrial fibrillation, CHA2DS2-VASc score of ≤1 and without anticoagulant therapy.Heart Vessels. 2016 Jul;31(7):1148-53. doi: 10.1007/s00380-015-0718-5. Epub 2015 Aug 1. Heart Vessels. 2016. PMID: 26231425
-
Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation.Stroke. 2008 Jun;39(6):1901-10. doi: 10.1161/STROKEAHA.107.501825. Epub 2008 Apr 17. Stroke. 2008. PMID: 18420954 Review.
-
Atrial fibrillation in the elderly.Clin Cardiol. 1996 Oct;19(10):765-75. doi: 10.1002/clc.4960191003. Clin Cardiol. 1996. PMID: 8896908 Review.
Cited by
-
Coronary Artery Embolism and Myocardial Infarction, case report.Arch Peru Cardiol Cir Cardiovasc. 2024 Mar 19;5(1):45-49. doi: 10.47487/apcyccv.v5i1.347. eCollection 2024 Jan-Mar. Arch Peru Cardiol Cir Cardiovasc. 2024. PMID: 38596603 Free PMC article.
-
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.Circulation. 2017 Mar 7;135(10):e146-e603. doi: 10.1161/CIR.0000000000000485. Epub 2017 Jan 25. Circulation. 2017. PMID: 28122885 Free PMC article. Review. No abstract available.
-
Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association.Circulation. 2023 Feb 21;147(8):e93-e621. doi: 10.1161/CIR.0000000000001123. Epub 2023 Jan 25. Circulation. 2023. PMID: 36695182 Free PMC article. Review.
-
Reversible thrombocytopenia during hibernation originates from storage and release of platelets in liver sinusoids.J Comp Physiol B. 2021 May;191(3):603-615. doi: 10.1007/s00360-021-01351-3. Epub 2021 Mar 4. J Comp Physiol B. 2021. PMID: 33661336 Free PMC article.
-
Effect of China national centralized drug procurement policy on anticoagulation selection and hemorrhage events in patients with AF in Suining.Front Pharmacol. 2024 Feb 20;15:1365142. doi: 10.3389/fphar.2024.1365142. eCollection 2024. Front Pharmacol. 2024. PMID: 38444941 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical